Markers indicating the progression of tumors (COX-2, Ki68, p65, TNF-α, β-catenin), alteration of tumor-related pathways mitogen-activated protein kinase (MAPK) and olfactory/G-protein-coupled receptor family (GPCR) have been measured [15,88,92,95]. The gene discussed is PTGS2; the disease is neoplasm.